Thursday, September 30, 2021 12:24:20 AM
"It could easily be interpreted to say that this thing (pandemic / virus) will go through society at its own pace, infecting both the vaccinated and unvaccinated the same way
initially (though lower chance of being infected if vaccinated). I do believe vaccination will save people from severe disease, but that's about all one can say for SARS2-delta infection, at least based on this study. Would like to see more data on SARS2-delta hospitalizations and severe disease based on vaccination status.
Some experts, including UK's Oxford Vaccine Group, have stated the only end to the pandemic and achieve herd immunity will be when the unvaccinated and vaccinated have been infected and achieve "natural immunity"
https://www.theguardian.com/world/2021/aug/10/delta-variant-renders-herd-immunity-from-covid-mythical
Others question the wisdom of vaccinating children.
https://khn.org/news/article/covid-vaccination-children-rare-side-effects-myocarditis-experts-caution/
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8437699/
I agree there is little US data on delta complications and vaccine complications. The best data has come from the UK and Israel.
Unfortunately the vaccines do not work as well as we had hoped against the delta variant. As long as the vaccinated can catch covid 19 and spread it there is little hope for herd immunity. It is clear vaccination is a benefit to the elderly and high risk individuals. It is less clear what benefit will come from vaccinating healthy children and young adults.
With those observations developing therapeutics should be a high priority.
Hopefully Brilacidin will prove useful against covid19.
GLTA,
Farrell
Recent IPIX News
- Form 8-K - Current report • Edgar (US Regulatory) • 02/01/2024 01:30:25 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 12/05/2023 09:25:58 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/20/2023 09:05:44 PM
- Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSB • Edgar (US Regulatory) • 11/15/2023 01:00:19 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/30/2023 08:15:25 PM
- Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 09/28/2023 01:00:08 PM
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM